Partnership seals move towards Digital Health Hub

The Luxembourg Institute of Health, a pioneer in translational medicine and digital health and venture capital investment firm Expon Capital, both based in Luxembourg city, have entered into a collaboration aiming to identify possible opportunities and synergies in the field of scientific research and technological development in the digital health sector.

Boasting a rapidly-evolving and thriving health-tech scene, enabled by the financial support of the Government, national funding agencies such as the Luxembourg National Research Fund (FNR), supranational institutions, as well as the cutting-edge expertise and infrastructure of its research institutes, ideally positions the country to attract dynamic and innovative health-tech companies and start-ups, particularly in the digital health area.

With venture capital also playing an equally key role in catalysing this ambitious vision, the project partners are intending to set a framework focused on the identification, development and possible implementation of a variety of specific projects and activities. These include the provision of support to LIH in setting up juries for hackathons and competitions, spin-offs and start-ups, as well as assistance related to other science commercialisation activities. LIH will be able to provide advisory and scientific support to Expon Capital and assist in joint strategies to develop partnerships between digital health companies and the financial and investor community.

“We are delighted to have entered into this agreement with a reputable Venture Capitalist with a profound knowledge of the national research and technology landscape. We believe that the numerous opportunities for knowledge transfer arising from this partnership and the availability of Expon’s financial and investment expertise to our researchers will create a bridge between research and its commercialisation. This will ensure that our scientific findings are marketable and can be translated into tangible healthcare solutions, easily accessible by clinicians and patients," stated Prof Ulf Nehrbass, Chief Executive Officer of LIH.

“We are looking forward to setting the basis for a solid and long-lasting strategic cooperation between the complementary worlds of research and finance here in the Grand Duchy, which will contribute to further attracting innovative and disruptive e-health companies, ultimately unlocking the potential of digital health and translational research and improving healthcare and patient outcomes," said Jérôme Wittamer, Managing Partner of Expon Capital.

More information online